British drugmaker AstraZeneca plans to increase its manufacturing potential to 2 billion doses of a COVID-19 vaccine, in two separate deals.
Categories
British drugmaker AstraZeneca plans to increase its manufacturing potential to 2 billion doses of a COVID-19 vaccine, in two separate deals.